StockData
Nuo Therapeutics, Inc. logo

Nuo Therapeutics, Inc. (AURX) stock

AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$1.26−0.04 (-3.08%)

Close on Oct 19, 2026Market cap $60.99MP/E –Yield –

Nuo Therapeutics operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Nuo Therapeutics's operating income for the twelve months ending Jun 30, 2026 was -$1.73M. For fiscal 2025 it was -$2.52M. The highest annual figure on record is -$90.67K in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.52M–
FY2024Dec 31, 2024-$2.46M–
FY2023Dec 31, 2023-$3.17M–
FY2022Dec 31, 2022-$3.32M–
FY2021Dec 31, 2021-$90.67K–
FY2020Dec 31, 2020-$378.06K–
FY2019Dec 31, 2019-$969.20K–
FY2018Dec 31, 2018-$1.50M–
FY2017Dec 31, 2017-$15.53M–
FY2015Dec 31, 2015-$41.32M–
FY2014Dec 31, 2014-$23.39M–
FY2013Dec 31, 2013-$18.10M–
FY2012Dec 31, 2012-$12.89M–
FY2011Dec 31, 2011-$3.51M–
FY2010Dec 31, 2010-$5.40M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$166.55K–
Q1 FY2026Mar 31, 2026-$446.47K–
Q4 FY2025Dec 31, 2025-$579.34K–
Q3 FY2025Sep 30, 2025-$540.14K–
Q2 FY2025Jun 30, 2025-$652.02K–
Q1 FY2025Mar 31, 2025-$745.15K–
Q4 FY2024Dec 31, 2024-$629.23K–
Q3 FY2024Sep 30, 2024-$577.37K–
Q2 FY2024Jun 30, 2024-$541.98K–
Q1 FY2024Mar 31, 2024-$709.25K–
Q4 FY2023Dec 31, 2023-$652.11K–
Q3 FY2023Sep 30, 2023-$789.55K–
Q2 FY2023Jun 30, 2023-$871.42K–
Q1 FY2023Mar 31, 2023-$855.19K–
Q4 FY2022Dec 31, 2022-$963.19K–
Q3 FY2022Sep 30, 2022-$911.87K–
Q2 FY2022Jun 30, 2022-$923.73K–
Q1 FY2022Mar 31, 2022-$521.82K–
Q4 FY2021Dec 31, 2021-$71.65K–
Q3 FY2021Sep 30, 2021-$6.75K–
Q2 FY2021Jun 30, 2021-$6.55K–
Q1 FY2021Mar 31, 2021-$5.72K–
Q4 FY2020Dec 31, 2020-$323.63K-538.7%
Q3 FY2020Sep 30, 2020-$6.25K–
Q2 FY2020Jun 30, 2020-$5.79K–
Q1 FY2020Mar 31, 2020-$42.38K–
Q4 FY2019Dec 31, 2019$73.77K-53.2%
Q3 FY2019Sep 30, 2019-$38.69K–
Q2 FY2019Jun 30, 2019-$392.45K–
Q1 FY2019Mar 31, 2019-$611.83K–
Q4 FY2018Dec 31, 2018$157.48K–
Q3 FY2018Sep 30, 2018-$411.79K–
Q2 FY2018Jun 30, 2018-$582.66K–
Q1 FY2018Mar 31, 2018-$667.73K–
Q4 FY2017Dec 31, 2017-$8.56M–
Q3 FY2017Sep 30, 2017-$1.38M–
Q2 FY2017Jun 30, 2017-$3.91M–
Q1 FY2017Mar 31, 2017-$1.68M–
Q3 FY2016Sep 30, 2016-$1.86M–

More Nuo Therapeutics figures

See a number that looks wrong?